IL105403A - Pharmaceutical preparation containing dichloromethylene bisphosphonic acid and process for its manufacture - Google Patents

Pharmaceutical preparation containing dichloromethylene bisphosphonic acid and process for its manufacture

Info

Publication number
IL105403A
IL105403A IL105403A IL10540393A IL105403A IL 105403 A IL105403 A IL 105403A IL 105403 A IL105403 A IL 105403A IL 10540393 A IL10540393 A IL 10540393A IL 105403 A IL105403 A IL 105403A
Authority
IL
Israel
Prior art keywords
tablet
film
bisphosphonic acid
preparation according
dissolves
Prior art date
Application number
IL105403A
Other languages
English (en)
Other versions
IL105403A0 (en
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of IL105403A0 publication Critical patent/IL105403A0/xx
Publication of IL105403A publication Critical patent/IL105403A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL105403A 1992-04-24 1993-04-15 Pharmaceutical preparation containing dichloromethylene bisphosphonic acid and process for its manufacture IL105403A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning

Publications (2)

Publication Number Publication Date
IL105403A0 IL105403A0 (en) 1993-08-18
IL105403A true IL105403A (en) 1998-03-10

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105403A IL105403A (en) 1992-04-24 1993-04-15 Pharmaceutical preparation containing dichloromethylene bisphosphonic acid and process for its manufacture

Country Status (21)

Country Link
US (1) US5525354A (fr)
EP (1) EP0637236B1 (fr)
JP (1) JP3536106B2 (fr)
AT (1) ATE143802T1 (fr)
AU (1) AU671830B2 (fr)
CA (1) CA2134196C (fr)
CZ (1) CZ282871B6 (fr)
DE (2) DE69305335T2 (fr)
DK (1) DK0637236T3 (fr)
EE (1) EE03107B1 (fr)
ES (1) ES2094539T3 (fr)
FI (1) FI110667B (fr)
GR (1) GR3022249T3 (fr)
HK (1) HK13097A (fr)
HU (1) HU219342B (fr)
IL (1) IL105403A (fr)
NO (1) NO306654B1 (fr)
RU (1) RU2116074C1 (fr)
SE (1) SE501389C2 (fr)
TW (1) TW273515B (fr)
WO (1) WO1993021907A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
DE59300688D1 (de) * 1993-05-15 1995-11-02 Boehringer Mannheim Gmbh Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff.
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998933A1 (fr) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Procédé pour la préparation de compositions pharmaucetiques contenant des diphosphonates pour administration orale
EP0998932A1 (fr) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Forme d'administration pharmaceutique contenant des diphosphonates ou leurs sels et méthode pour la fabriquer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
ATE386508T1 (de) * 1999-02-22 2008-03-15 Merrion Res I Ltd Feste orale dosierungsform enthaltend einen resorptionsverstärker
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
WO2002092069A1 (fr) 2001-05-11 2002-11-21 Elan Corporation, Plc Renforcateur de permeation
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
KR20110007242A (ko) 2008-05-07 2011-01-21 메리온 리서치 Ⅲ 리미티드 펩티드 조성물 및 그의 제조 방법
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2011120033A1 (fr) 2010-03-26 2011-09-29 Merrion Research Iii Limited Compositions pharmaceutiques d'inhibiteurs de facteur xa sélectifs destinées à une administration orale
WO2012094598A2 (fr) 2011-01-07 2012-07-12 Merrion Research Iii Limited Compositions pharmaceutiques de fer pour administration orale
CN107205948B (zh) 2015-01-29 2021-12-14 诺和诺德股份有限公司 包含glp-1激动剂和肠溶衣的片剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
ATE60711T1 (de) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
CA2134196C (fr) 2004-02-10
RU94045950A (ru) 1996-11-10
GR3022249T3 (en) 1997-04-30
NO944001D0 (no) 1994-10-21
JPH07505898A (ja) 1995-06-29
FI944961A (fi) 1994-10-21
AU3955093A (en) 1993-11-29
HU9403067D0 (en) 1994-12-28
HUT74572A (en) 1997-01-28
JP3536106B2 (ja) 2004-06-07
TW273515B (fr) 1996-04-01
IL105403A0 (en) 1993-08-18
AU671830B2 (en) 1996-09-12
SE9201299L (sv) 1993-10-25
EP0637236B1 (fr) 1996-10-09
RU2116074C1 (ru) 1998-07-27
DK0637236T3 (da) 1997-03-17
NO306654B1 (no) 1999-12-06
SE9201299D0 (sv) 1992-04-24
CZ282871B6 (cs) 1997-11-12
DE69305335T2 (de) 1997-04-30
DE69305335D1 (de) 1996-11-14
EP0637236A1 (fr) 1995-02-08
HU219342B (en) 2001-03-28
ATE143802T1 (de) 1996-10-15
FI944961A0 (fi) 1994-10-21
DE637236T1 (de) 1995-07-06
ES2094539T3 (es) 1997-01-16
NO944001L (no) 1994-10-21
WO1993021907A1 (fr) 1993-11-11
US5525354A (en) 1996-06-11
EE03107B1 (et) 1998-08-17
CZ261494A3 (en) 1995-02-15
FI110667B (fi) 2003-03-14
HK13097A (en) 1997-02-14
SE501389C2 (sv) 1995-01-30
CA2134196A1 (fr) 1993-11-11

Similar Documents

Publication Publication Date Title
US5525354A (en) Pharmaceutical preparation and process for its manufacture
US6010718A (en) Extended release formulations of erythromycin derivatives
US5520931A (en) Controlled release morphine preparation
US6872407B2 (en) Extended release formulations of erythromycin derivatives
KR100348585B1 (ko) 다리페나신을함유하는약학제제
US5811126A (en) Controlled release matrix for pharmaceuticals
EP0255404B1 (fr) Préparation d'ibuprofen à libération prolongée
EP0717986B1 (fr) Rotogranulation et enrobage d'acetaminophène, pseudoéphédrine, chlorphéniramine, et, éventuellement, dextrométhorphane
HU196708B (en) Process for producing pharmaceutical composition comprising omeprazol and suitable for treating deseases of the digestive system
EP0221732A2 (fr) Comprimés à effet retardé
JP2002508311A (ja) ＨＭＧ−ＣｏＡ還元酵素阻害剤の徐放性改良製剤
JPH11171775A (ja) テオフィリン徐放性錠剤
US20060159758A1 (en) Coating composition for taste masking coating and methods for their application and use
WO1998026767A2 (fr) Formulations a liberation lente et specifique d'un site, pour l'administration de mesalazine
WO2008083561A1 (fr) Composition pharmaceutique orale de glycyrrhizine ou ses sels et son procédé de préparation
MXPA05004648A (es) Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
IE57220B1 (en) Ph independent controlled releasable tablets
JP2016503782A (ja) Ｎ−［５−［２−（３，５−ジメトキシフェニル）エチル］−２ｈ−ピラゾール−３−イル］−４−［（３ｒ，５ｓ）−３，５−ジメチルピペラジン−１−イル］ベンズアミドの医薬製剤
Nykänen et al. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery
KR0184350B1 (ko) 오메프라졸 구강점막 부착 정제 조성물
WO2004032904A1 (fr) Compositions pharmaceutiques contenant des alginates
CN115804774A (zh) 一种噁拉戈利的药物组合物，包含其的药物制剂，及其应用

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees